Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 12616965
Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002;24(10):703-29
Bayés, M., Rabasseda, X., & Prous, J. R. (2002). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 24(10), 703-29.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 24,10 (2002): 703-29.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29. PMID: 12616965.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 15148527
Methods Find Exp Clin Pharmacol. 2004 Apr;26(3):211-44.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies Knowledge Area of Prous Science Integrity(R), the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2004;26(3):211-44
Bayés, M., Rabasseda, X., & Prous, J. R. (2004). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 26(3), 211-44.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 26,3 (2004): 211-44.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2004 Apr;26(3):211-44. PMID: 15148527.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayes M, Rabasseda X, Prous JR.
PMID: 16082427
Methods Find Exp Clin Pharmacol. 2005 May;27(4):265-84.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug...

Cite
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005;27(4):265-84
Bayes, M., Rabasseda, X., & Prous, J. R. (2005). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 27(4), 265-84.
Bayes, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 27,4 (2005): 265-84.
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2005 May;27(4):265-84. PMID: 16082427.
Copy Download .nbib Format: NLM
Advances in management of type 1 diabetes mellitus.

World journal of diabetes

Aathira R, Jain V.
PMID: 25317246
World J Diabetes. 2014 Oct 15;5(5):689-96. doi: 10.4239/wjd.v5.i5.689.

Treatment of type 1 diabetes mellitus has always posed a challenge to balance hyperglycemia control with hypoglycemia episodes. The quest for newer therapies is continuing and this review attempts to outline the recent developments. The insulin molecule itself has...

Cite
Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World J Diabetes. 2014;5(5):689-96doi: 10.4239/wjd.v5.i5.689.
Aathira, R., & Jain, V. (2014). Advances in management of type 1 diabetes mellitus. World journal of diabetes, 5(5), 689-96. https://doi.org/10.4239/wjd.v5.i5.689
Aathira, Ravindranath, and Jain, Vandana. "Advances in management of type 1 diabetes mellitus." World journal of diabetes vol. 5,5 (2014): 689-96. doi: https://doi.org/10.4239/wjd.v5.i5.689
Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World J Diabetes. 2014 Oct 15;5(5):689-96. doi: 10.4239/wjd.v5.i5.689. PMID: 25317246; PMCID: PMC4138592.
Copy Download .nbib Format: NLM
The role of glucagon on type 2 diabetes at a glance.

Diabetology & metabolic syndrome

Godoy-Matos AF.
PMID: 25177371
Diabetol Metab Syndr. 2014 Aug 24;6(1):91. doi: 10.1186/1758-5996-6-91. eCollection 2014.

The opposite effects of insulin and glucagon in fuel homeostasis, the paracrine/endocrine inhibitory effects of insulin on glucagon secretion and the hyperglucagonemia in the pathogenesis of type 2 diabetes (T2D) have long been recognized. Inappropriately increased alpha-cell function importantly...

Cite
Godoy-Matos AF. The role of glucagon on type 2 diabetes at a glance. Diabetol Metab Syndr. 2014;6(1):91doi: 10.1186/1758-5996-6-91.
Godoy-Matos, A. F. (2014). The role of glucagon on type 2 diabetes at a glance. Diabetology & metabolic syndrome, 6(1), 91. https://doi.org/10.1186/1758-5996-6-91
Godoy-Matos, Amélio F. "The role of glucagon on type 2 diabetes at a glance." Diabetology & metabolic syndrome vol. 6,1 (2014): 91. doi: https://doi.org/10.1186/1758-5996-6-91
Godoy-Matos AF. The role of glucagon on type 2 diabetes at a glance. Diabetol Metab Syndr. 2014 Aug 24;6(1):91. doi: 10.1186/1758-5996-6-91. eCollection 2014. PMID: 25177371; PMCID: PMC4148933.
Copy Download .nbib Format: NLM
Amylin as a Future Obesity Treatment.

Journal of obesity & metabolic syndrome

Dehestani B, Stratford NR, Roux CWL.
PMID: 34929674
J Obes Metab Syndr. 2021 Dec 30;30(4):320-325. doi: 10.7570/jomes21071.

Obesity is defined as abnormal or excessive fat accumulation that contributes to detrimental health impacts. One-third of the population suffers from obesity, and it is important to consider obesity as a chronic disease requiring chronic treatment. Amylin is co-secreted...

Cite
Dehestani B, Stratford NR, Roux CWL. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021;30(4):320-325doi: 10.7570/jomes21071.
Dehestani, B., Stratford, N. R., & Roux, C. W. L. (2021). Amylin as a Future Obesity Treatment. Journal of obesity & metabolic syndrome, 30(4), 320-325. https://doi.org/10.7570/jomes21071
Dehestani, Babak, et al. "Amylin as a Future Obesity Treatment." Journal of obesity & metabolic syndrome vol. 30,4 (2021): 320-325. doi: https://doi.org/10.7570/jomes21071
Dehestani B, Stratford NR, Roux CWL. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021 Dec 30;30(4):320-325. doi: 10.7570/jomes21071. PMID: 34929674.
Copy Download .nbib Format: NLM
Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.

Canadian journal of diabetes

Majdpour D, Tsoukas MA, Yale JF, El Fathi A, Rutkowski J, Rene J, Garfield N, Legault L, Haidar A.
PMID: 33888413
Can J Diabetes. 2021 Dec;45(8):734-742. doi: 10.1016/j.jcjd.2021.02.002. Epub 2021 Feb 20.

OBJECTIVES: A fully automated insulin-pramlintide-glucagon artificial pancreas that alleviates the burden of carbohydrate counting without degrading glycemic control was iteratively enhanced until convergence through pilot experiments on adults with type 1 diabetes.METHODS: Nine participants (age, 37±13 years; glycated hemoglobin,...

Cite
Majdpour D, Tsoukas MA, Yale JF, et al. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments. Can J Diabetes. 2021;45(8):734-742doi: 10.1016/j.jcjd.2021.02.002.
Majdpour, D., Tsoukas, M. A., Yale, J. F., El Fathi, A., Rutkowski, J., Rene, J., Garfield, N., Legault, L., & Haidar, A. (2021). Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments. Canadian journal of diabetes, 45(8), 734-742. https://doi.org/10.1016/j.jcjd.2021.02.002
Majdpour, Dorsa, et al. "Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments." Canadian journal of diabetes vol. 45,8 (2021): 734-742. doi: https://doi.org/10.1016/j.jcjd.2021.02.002
Majdpour D, Tsoukas MA, Yale JF, El Fathi A, Rutkowski J, Rene J, Garfield N, Legault L, Haidar A. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments. Can J Diabetes. 2021 Dec;45(8):734-742. doi: 10.1016/j.jcjd.2021.02.002. Epub 2021 Feb 20. PMID: 33888413.
Copy Download .nbib Format: NLM
Pramlintide as an adjunct to insulin therapy.

Current diabetes reports

Chu NV, Edelman SV.
PMID: 12685439
Curr Diab Rep. 2003 Feb;3(1):35-6. doi: 10.1007/s11892-003-0050-9.

No abstract available.

Cite
Chu NV, Edelman SV. Pramlintide as an adjunct to insulin therapy. Curr Diab Rep. 2003;3(1):35-6doi: 10.1007/s11892-003-0050-9.
Chu, N. V., & Edelman, S. V. (2003). Pramlintide as an adjunct to insulin therapy. Current diabetes reports, 3(1), 35-6. https://doi.org/10.1007/s11892-003-0050-9
Chu, Neelima V, and Edelman, Steven V. "Pramlintide as an adjunct to insulin therapy." Current diabetes reports vol. 3,1 (2003): 35-6. doi: https://doi.org/10.1007/s11892-003-0050-9
Chu NV, Edelman SV. Pramlintide as an adjunct to insulin therapy. Curr Diab Rep. 2003 Feb;3(1):35-6. doi: 10.1007/s11892-003-0050-9. PMID: 12685439.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 12616707
Methods Find Exp Clin Pharmacol. 2002 Nov;24(9):615-43.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002;24(9):615-43
Bayés, M., Rabasseda, X., & Prous, J. R. (2002). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 24(9), 615-43.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 24,9 (2002): 615-43.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002 Nov;24(9):615-43. PMID: 12616707.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 12690708
Methods Find Exp Clin Pharmacol. 2003 Jan-Feb;25(1):53-76.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003;25(1):53-76
Bayés, M., Rabasseda, X., & Prous, J. R. (2003). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 25(1), 53-76.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 25,1 (2003): 53-76.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003 Jan-Feb;25(1):53-76. PMID: 12690708.
Copy Download .nbib Format: NLM
Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts.

Scientific reports

Mousa YM, Abdallah IM, Hwang M, Martin DR, Kaddoumi A.
PMID: 32606448
Sci Rep. 2020 Jul 01;10(1):11096. doi: 10.1038/s41598-020-68281-y.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Mousa YM, Abdallah IM, Hwang M, et al. Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts. Sci Rep. 2020;10(1):11096doi: 10.1038/s41598-020-68281-y.
Mousa, Y. M., Abdallah, I. M., Hwang, M., Martin, D. R., & Kaddoumi, A. (2020). Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts. Scientific reports, 10(1), 11096. https://doi.org/10.1038/s41598-020-68281-y
Mousa, Youssef M, et al. "Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts." Scientific reports vol. 10,1 (2020): 11096. doi: https://doi.org/10.1038/s41598-020-68281-y
Mousa YM, Abdallah IM, Hwang M, Martin DR, Kaddoumi A. Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts. Sci Rep. 2020 Jul 01;10(1):11096. doi: 10.1038/s41598-020-68281-y. PMID: 32606448; PMCID: PMC7327050.
Copy Download .nbib Format: NLM
Pramlintide: profile of an amylin analog.

Expert review of endocrinology & metabolism

Lebovitz HE.
PMID: 30754127
Expert Rev Endocrinol Metab. 2012 Nov;7(6):599-609. doi: 10.1586/eem.12.50.

Amylin is a naturally occurring hormone that regulates food intake and postprandial glucose excursions. Amylin is synthesized in the β cell and cosecreted with insulin. Type 1 diabetes and insulin-requiring Type 2 diabetes are amylin-deficient as well as insulin-deficient...

Cite
Lebovitz HE. Pramlintide: profile of an amylin analog. Expert Rev Endocrinol Metab. 2012;7(6):599-609doi: 10.1586/eem.12.50.
Lebovitz, H. E. (2012). Pramlintide: profile of an amylin analog. Expert review of endocrinology & metabolism, 7(6), 599-609. https://doi.org/10.1586/eem.12.50
Lebovitz, Harold E. "Pramlintide: profile of an amylin analog." Expert review of endocrinology & metabolism vol. 7,6 (2012): 599-609. doi: https://doi.org/10.1586/eem.12.50
Lebovitz HE. Pramlintide: profile of an amylin analog. Expert Rev Endocrinol Metab. 2012 Nov;7(6):599-609. doi: 10.1586/eem.12.50. PMID: 30754127.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries